Navigation Links
Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
Date:1/4/2012

THOUSAND OAKS, Calif., Jan. 4, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 30th Annual J.P. Morgan Global Healthcare Conference at 10:00 a.m. Pacific Time on Monday, Jan. 9, 2012, at the Westin St. Francis in San Francisco, Calif.  Robert A. Bradway, president and chief operating officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com.  Follow us on www.twitter.com/amgen.

 

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

 

 

 

 


'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
2. Amgen Announces 2012 First Quarter Dividend
3. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
4. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
5. Amgen’s Third Quarter 2011 Revenue and Adjusted Earnings Per Share (EPS) Each Increased 3 Percent to $3.9 Billion and $1.40
6. Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations
7. Amgen Appoints Robert A. Bradway to the Companys Board of Directors
8. Amgen Announces 2011 Fourth Quarter Dividend
9. Amgen to Present at the UBS Global Life Sciences Conference
10. Amgen Staff Volunteer Efforts Result in $5,000 For Each of Their Favorite Nonprofits
11. Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... AACC welcomed thousands of medical professionals ... Meeting & Clinical Lab Expo in ... showcased revolutionary advancements in clinical testing technology and ... to diagnose patients quickly and accurately and make ... As of Wednesday, July 29, more than ...
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
(Date:7/30/2015)... 60,000 customers across the globe, ISN improves the efficiency and effectiveness of contractor management ... safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 ... Headquartered in Dallas, TX , ISN has additional offices in ...
(Date:7/30/2015)... , ... July 30, 2015 , ... As part of its 2015 growth plan and ... and technical service business units, Whitehouse Laboratories is pleased to announce that it ... to the Container Center of Excellence and will be strictly dedicated to basic USP 51, ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2
... Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today ... offer (the "Exchange Offer") to exchange shares of its common ... aggregate of $89.2 million principal amount for the following outstanding ... , 4% Convertible Senior ...
... , - German Chemical Parks Record ... The number of employees in German chemical parks has ... this same period, the number of,companies doing business at these ... by Dr. Klaus-Dieter Juszak, Chairman of the,German Sector Group of ...
... (NYSE: LLY ) will unveil data from more ... American Society of Clinical Oncology (ASCO) in Orlando, Fla. from ... the presentations continuing to support Lilly,s leadership in thoracic cancer ... on ALIMTA(R) (pemetrexed for injection), as well as GEMZAR(R) (gemcitabine ...
Cached Biology Technology:Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 2Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 3Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 4Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 5Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer 610,000 New Jobs, Investments Increased 210,000 New Jobs, Investments Increased 3Lilly Set to Unveil More Than 50 Studies at ASCO 2009 2Lilly Set to Unveil More Than 50 Studies at ASCO 2009 3Lilly Set to Unveil More Than 50 Studies at ASCO 2009 4Lilly Set to Unveil More Than 50 Studies at ASCO 2009 5Lilly Set to Unveil More Than 50 Studies at ASCO 2009 6
(Date:7/31/2015)... , 31 de julio de 2015 La ... ) se celebrará por medio de BGI del 22 al 25 ... . Este año, la conferencia celebra su ... se ha convertido en una de las reuniones anuales más ... una de las reuniones más dinámicas, entusiastas y mejores a ...
(Date:7/31/2015)... , July 31, 2015 The 10 th ... held by BGI from October 22-25, 2015, in Shenzhen ... The conference is celebrating its 10 th anniversary this year. ... the world,s most influential annual meetings in the ,omics, fields, ... scientific gatherings. ICG-10 focuses on recent breakthroughs ...
(Date:7/27/2015)... 27, 2015   Zynx Health ™, the ... improvement solutions, today announced that its ZynxCarebook ... on Android smartphones and tablets. With this expansion, ... can use ZynxCarebook to securely exchange messages and ... care transitions to other care settings, and improve ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3
... genetic material in our cells are iconically depicted as ... cell is about to divide and the entire contents of ... to get a good picture of the way that our ... is neatly bundled into the nucleus while enabling day-to-day (non-dividing) ...
... (Nov. 25 2013) After Schwann cells (SCs), the principal ... (OECs), cells that ensheath the non-myelinated peripheral neurons in the ... researchers in Beijing, China put the rats on a 30 ... determine if the effects of the workouts would benefit aspects ...
... as they are "smart": too elementary to be able to ... by inserting pieces of their own DNA so that it ... first have to inject their own genetic material into the ... Micheletti from SISSA (the International School for Advanced Studies in ...
Cached Biology News:Chromosomes show off their shapes 2Co-transplanted cells and treadmill training aids rats with spinal cord injury 2Tidy knots are faster 2
...
... Fingerprinting II ... is an optional ... principal component analysis, ... analysis and MANOVA, ...
Fingerprinting II Informatix optional matrix types module, is an optional module that adds external similarity and distance matrix functions to the Fingerprinting II Informatix software package....
... thermal cycler is a completely redesigned and ... and it accepts the full line of ... same precision in thermal performance as the ... cyclers, allowing easy transport of protocols among ...
Biology Products: